Jose M. Jimeno
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor.
Journal: Molecular aspects of medicine
Published: May 13, 2025
Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment.
Journal: Infectious diseases (London, England)
Published: May 14, 2024
A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 21, 2023
Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: April 30, 2023
SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
Journal: Cell
Published: December 20, 2022
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis.
Journal: Frontiers in cellular and infection microbiology
Published: November 14, 2022
Long-term outcomes of bilateral breast reduction in women with obesity and symptomatic macromastia. A cohort study.
Journal: Journal of plastic, reconstructive & aesthetic surgery : JPRAS
Published: October 07, 2022
Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia.
Journal: Journal of hematology & oncology
Published: November 20, 2021
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.
Journal: Life science alliance
Published: August 18, 2021
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization.
Journal: medRxiv : the preprint server for health sciences
Published: June 02, 2021
Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 25, 2021
Safety of cancer surgery during the COVID-19 pandemic.
Journal: The British journal of surgery
Published: May 13, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026